Building Bridges Between Academia and Big Pharma
How does one of the world's leading pharmaceutical companies innovate and find new external opportunities? How can academics benefit from it?
Join us to hear firsthand from Johnson & Johnson how the company scouts, evaluates, and pursues external innovation, from collaborations to acquisitions. Whether you're a researcher wondering how your work catches industry attention or simply curious about how Big Pharma thinks, this is a session not to miss.
The afternoon will include a Q&A and plenty of time to connect with the speaker and fellow participants.
Join us to hear firsthand from Johnson & Johnson how the company scouts, evaluates, and pursues external innovation, from collaborations to acquisitions. Whether you're a researcher wondering how your work catches industry attention or simply curious about how Big Pharma thinks, this is a session not to miss.
The afternoon will include a Q&A and plenty of time to connect with the speaker and fellow participants.
Zeit
Mittwoch, 29.04.26 - 14:00 Uhr
- 16:00 Uhr
Veranstaltungsformat
Vortrag
Themengebiet
Innovation, Pharma Industry, Research
Referierende
Ralf Angermund, Director Search & Evaluation Germany, External Scientific Innovation at Johnson & Johnson
Zielgruppen
Studierende
Wissenschaftler*innen
Sprachen
Englisch
Ort
University Hospital Bonn, BMZ II
Reservierung
erforderlich
Link zu Anmeldung/Ticket
Veranstalter
Transfer Center enaCom, Nucleate Germany, Universitätsklinikum Bonn
Kontakt